Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, Alliance Global Partners reiterated a “buy” rating on shares of Evogene in a research note on Friday, March 7th. Get Our Latest Report on EVGN […]
